Mesa Historical Balance Sheet

MLAB Stock

USD 122.80 2.62 2.09%

Trend analysis of Mesa Laboratories balance sheet accounts such as Total Stockholder Equity of 175.6 M provides information on Mesa Laboratories' total assets, liabilities, and equity, which is the actual value of Mesa Laboratories to its prevalent stockholders. By breaking down trends over time using Mesa Laboratories balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Mesa Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mesa Laboratories is a good buy for the upcoming year.

Mesa Laboratories Inventory

39.46 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.

About Mesa Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Mesa Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Mesa Laboratories Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Mesa Laboratories and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Mesa currently owns. An asset can also be divided into two categories, current and non-current.

Mesa Laboratories Balance Sheet Chart

At present, Mesa Laboratories' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 22 M, whereas Retained Earnings are projected to grow to (200.5 M).

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Mesa Laboratories assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Mesa Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Mesa Laboratories balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Mesa Laboratories are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Mesa Laboratories' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Mesa Laboratories current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.At present, Mesa Laboratories' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 22 M, whereas Retained Earnings are projected to grow to (200.5 M).

	2022	2023	2024	2025 (projected)
Other Current Liabilities	20.0M	18.2M	20.9M	22.0M
Total Assets	661.8M	446.8M	513.8M	539.5M

Other Current Liab Total Assets

Mesa Laboratories balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Total	Other Current Assets	Short Long Term Debt Total	Accounts Payable	Short Term Debt	Intangible Assets	Common Stock Total Equity
Total Assets		0.76	0.91	0.91	0.73	0.55	-0.28	0.53	0.97	0.31	0.56	0.53	0.91	0.87	0.78	0.42	0.92	0.8	0.82	0.92	0.26	0.9	0.92	-0.13	0.78	0.94
Other Current Liab	0.76		0.93	0.53	0.89	0.77	-0.5	0.1	0.8	0.08	0.08	0.1	0.89	0.73	0.89	0.07	0.86	0.9	0.48	0.84	0.32	0.84	0.87	-0.42	0.56	0.78
Total Current Liabilities	0.91	0.93		0.69	0.91	0.77	-0.55	0.28	0.92	0.04	0.36	0.28	0.98	0.86	0.92	0.3	0.97	0.95	0.66	0.96	0.16	0.96	0.99	-0.29	0.76	0.94
Total Stockholder Equity	0.91	0.53	0.69		0.44	0.2	0.1	0.68	0.86	0.53	0.68	0.68	0.68	0.73	0.5	0.47	0.68	0.52	0.83	0.67	0.35	0.65	0.72	0.01	0.63	0.75
Property Plant And Equipment Net	0.73	0.89	0.91	0.44		0.81	-0.7	0.13	0.74	-0.08	0.1	0.13	0.9	0.74	0.9	0.08	0.89	0.97	0.51	0.88	0.06	0.9	0.86	-0.36	0.64	0.83
Net Debt	0.55	0.77	0.77	0.2	0.81		-0.73	-0.33	0.68	-0.38	0.03	-0.33	0.83	0.59	0.89	0.22	0.8	0.88	0.1	0.79	0.14	0.8	0.77	-0.42	0.55	0.68
Retained Earnings	-0.28	-0.5	-0.55	0.1	-0.7	-0.73		0.12	-0.3	0.49	0.23	0.12	-0.58	-0.46	-0.68	0.18	-0.61	-0.68	-0.19	-0.62	0.31	-0.65	-0.5	0.16	-0.33	-0.59
Cash	0.53	0.1	0.28	0.68	0.13	-0.33	0.12		0.33	0.65	0.49	1.0	0.21	0.43	0.03	0.1	0.3	0.08	0.9	0.3	-0.08	0.3	0.27	0.28	0.38	0.44
Non Current Assets Total	0.97	0.8	0.92	0.86	0.74	0.68	-0.3	0.33		0.2	0.53	0.33	0.93	0.85	0.84	0.48	0.92	0.85	0.66	0.92	0.34	0.9	0.94	-0.22	0.76	0.91
Non Currrent Assets Other	0.31	0.08	0.04	0.53	-0.08	-0.38	0.49	0.65	0.2		0.08	0.65	0.01	0.13	-0.06	-0.19	0.06	-0.12	0.53	0.06	0.59	0.04	0.01	-0.02	-0.01	0.09
Other Assets	0.56	0.08	0.36	0.68	0.1	0.03	0.23	0.49	0.53	0.08		0.49	0.32	0.4	0.1	0.91	0.35	0.19	0.5	0.35	-0.21	0.33	0.46	0.2	0.73	0.4
Cash And Short Term Investments	0.53	0.1	0.28	0.68	0.13	-0.33	0.12	1.0	0.33	0.65	0.49		0.21	0.43	0.03	0.1	0.3	0.08	0.9	0.3	-0.09	0.3	0.27	0.28	0.38	0.44
Net Receivables	0.91	0.89	0.98	0.68	0.9	0.83	-0.58	0.21	0.93	0.01	0.32	0.21		0.86	0.96	0.29	0.98	0.97	0.61	0.97	0.23	0.97	0.98	-0.23	0.72	0.95
Common Stock Shares Outstanding	0.87	0.73	0.86	0.73	0.74	0.59	-0.46	0.43	0.85	0.13	0.4	0.43	0.86		0.78	0.29	0.87	0.8	0.7	0.86	0.14	0.86	0.86	-0.17	0.67	0.89
Inventory	0.78	0.89	0.92	0.5	0.9	0.89	-0.68	0.03	0.84	-0.06	0.1	0.03	0.96	0.78		0.12	0.93	0.96	0.46	0.92	0.29	0.93	0.91	-0.3	0.58	0.88
Other Stockholder Equity	0.42	0.07	0.3	0.47	0.08	0.22	0.18	0.1	0.48	-0.19	0.91	0.1	0.29	0.29	0.12		0.3	0.2	0.17	0.3	-0.19	0.27	0.42	0.09	0.71	0.28
Total Liab	0.92	0.86	0.97	0.68	0.89	0.8	-0.61	0.3	0.92	0.06	0.35	0.3	0.98	0.87	0.93	0.3		0.94	0.68	1.0	0.14	1.0	0.96	-0.24	0.79	0.97
Property Plant And Equipment Gross	0.8	0.9	0.95	0.52	0.97	0.88	-0.68	0.08	0.85	-0.12	0.19	0.08	0.97	0.8	0.96	0.2	0.94		0.5	0.93	0.14	0.94	0.93	-0.33	0.66	0.89
Total Current Assets	0.82	0.48	0.66	0.83	0.51	0.1	-0.19	0.9	0.66	0.53	0.5	0.9	0.61	0.7	0.46	0.17	0.68	0.5		0.68	0.02	0.68	0.64	0.13	0.61	0.78
Non Current Liabilities Total	0.92	0.84	0.96	0.67	0.88	0.79	-0.62	0.3	0.92	0.06	0.35	0.3	0.97	0.86	0.92	0.3	1.0	0.93	0.68		0.14	1.0	0.95	-0.23	0.79	0.97
Other Current Assets	0.26	0.32	0.16	0.35	0.06	0.14	0.31	-0.08	0.34	0.59	-0.21	-0.09	0.23	0.14	0.29	-0.19	0.14	0.14	0.02	0.14		0.1	0.15	-0.29	-0.2	0.09
Short Long Term Debt Total	0.9	0.84	0.96	0.65	0.9	0.8	-0.65	0.3	0.9	0.04	0.33	0.3	0.97	0.86	0.93	0.27	1.0	0.94	0.68	1.0	0.1		0.95	-0.24	0.78	0.97
Accounts Payable	0.92	0.87	0.99	0.72	0.86	0.77	-0.5	0.27	0.94	0.01	0.46	0.27	0.98	0.86	0.91	0.42	0.96	0.93	0.64	0.95	0.15	0.95		-0.22	0.81	0.94
Short Term Debt	-0.13	-0.42	-0.29	0.01	-0.36	-0.42	0.16	0.28	-0.22	-0.02	0.2	0.28	-0.23	-0.17	-0.3	0.09	-0.24	-0.33	0.13	-0.23	-0.29	-0.24	-0.22		-0.1	-0.11
Intangible Assets	0.78	0.56	0.76	0.63	0.64	0.55	-0.33	0.38	0.76	-0.01	0.73	0.38	0.72	0.67	0.58	0.71	0.79	0.66	0.61	0.79	-0.2	0.78	0.81	-0.1		0.74
Common Stock Total Equity	0.94	0.78	0.94	0.75	0.83	0.68	-0.59	0.44	0.91	0.09	0.4	0.44	0.95	0.89	0.88	0.28	0.97	0.89	0.78	0.97	0.09	0.97	0.94	-0.11	0.74

Click cells to compare fundamentals

Mesa Laboratories Account Relationship Matchups

Mesa Laboratories balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	600.2M	707.4M	661.8M	446.8M	513.8M	539.5M
Other Current Liab	9.9M	14.8M	20.0M	18.2M	20.9M	22.0M
Total Current Liabilities	32.6M	48.1M	43.4M	44.3M	51.0M	53.5M
Total Stockholder Equity	406.2M	393.8M	393.5M	145.4M	167.2M	175.6M
Property Plant And Equipment Net	22.0M	28.6M	28.1M	41.4M	47.7M	50.0M
Net Debt	(117.2M)	171.8M	137.4M	203.1M	233.5M	245.2M
Retained Earnings	72.5M	76.7M	74.2M	(183.5M)	(211.0M)	(200.5M)
Cash	263.9M	49.3M	32.9M	28.2M	32.4M	17.3M
Non Current Assets Total	297.1M	583.1M	542.9M	337.4M	388.1M	407.5M
Non Currrent Assets Other	275.1M	11.8M	209.0M	867K	997.1K	947.2K
Other Assets	275.1M	554.4M	2.8M	1.0	1.15	1.09
Cash And Short Term Investments	263.9M	49.3M	32.9M	28.2M	32.4M	17.5M
Net Receivables	23.8M	41.2M	42.6M	39.1M	44.9M	47.2M
Common Stock Shares Outstanding	5.1M	5.3M	5.4M	5.4M	6.2M	4.3M
Liabilities And Stockholders Equity	600.2M	707.4M	661.8M	446.8M	513.8M	539.5M
Inventory	11.2M	24.6M	34.6M	32.7M	37.6M	39.5M
Other Stockholder Equity	16.1M	323.1M	(12.8M)	(1.0)	(1.15)	(1.09)
Total Liab	193.9M	313.6M	268.4M	301.4M	346.6M	363.9M
Property Plant And Equipment Gross	22.0M	46.3M	47.9M	54.3M	62.4M	65.5M
Total Current Assets	303.0M	124.3M	119.0M	109.4M	125.8M	132.0M
Accumulated Other Comprehensive Income	16.1M	3.7M	(12.8M)	(14.8M)	(13.3M)	(12.6M)
Non Current Liabilities Total	162.7M	265.5M	225.0M	257.1M	295.7M	310.4M
Other Current Assets	4.9M	9.1M	86.1M	9.4M	10.8M	10.2M
Short Long Term Debt Total	146.7M	221.1M	186.1M	231.3M	266.0M	279.3M
Accounts Payable	4.5M	7.9M	6.1M	6.0M	6.9M	7.3M
Short Term Debt	14.8M	6.9M	2.9M	3.0M	3.4M	4.5M
Intangible Assets	111.7M	250.1M	18.2M	113.8M	130.8M	137.4M
Common Stock Total Equity	39.8M	158.0M	317.7M	332.1M	381.9M	401.0M
Common Stock	317.7M	313.5M	332.1M	343.6M	395.2M	414.9M
Property Plant Equipment	22.1M	22.0M	28.6M	28.1M	32.4M	34.0M
Good Will	160.8M	291.2M	286.4M	180.1M	207.1M	217.5M
Current Deferred Revenue	8.8M	14.6M	14.4M	15.5M	17.8M	18.7M
Long Term Debt	145.7M	218.4M	183.3M	221.7M	255.0M	267.7M
Net Tangible Assets	(41.4M)	294.5M	393.8M	107.0M	123.1M	101.8M
Retained Earnings Total Equity	73.3M	71.9M	72.5M	74.2M	85.3M	68.3M
Other Liab	32.6M	193.9M	39.7M	36.0M	41.4M	32.9M
Long Term Debt Total	20.6M	140.3M	145.7M	183.3M	210.8M	221.3M
Non Current Liabilities Other	715K	7.9M	7.7M	15.6M	18.0M	18.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:

How To Invest In Mesa

Details

Is Mesa Stock a good investment?

Details

What is Mesa Laboratories' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.

You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

3.875

Dividend Share

0.64

Earnings Share

(46.32)

Revenue Per Share

43.964

Quarterly Revenue Growth

0.175

The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mesa Historical Balance Sheet

Mesa Laboratories Inventory

39.46 Million

About Mesa Balance Sheet Analysis

Mesa Laboratories Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Mesa Laboratories balance sheet Correlations

Mesa Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Mesa Laboratories balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 1.0	Total Liab
Short Long Term Debt Total	+ 1.0	Total Liab
Short Long Term Debt Total	+ 1.0	Non Current Liabilities Total
Accounts Payable	+ 0.99	Total Current Liabilities
Net Receivables	+ 0.98	Total Current Liabilities

Retained Earnings	- 0.73	Net Debt
Retained Earnings	- 0.7	Property Plant And Equipment Net
Property Plant And Equipment Gross	- 0.68	Retained Earnings
Inventory	- 0.68	Retained Earnings
Short Long Term Debt Total	- 0.65	Retained Earnings
Non Current Liabilities Total	- 0.62	Retained Earnings